BioFlash

San Francisco Business Times
  • ٥٫٠ (٣)
  • الأعمال

BioFlash is a biweekly podcast, hosted by San Francisco Business Times biotech reporter Ron Leuty. From cancer immunotherapy to drug pricing, we explore the hot topics driving the life sciences ecosystem in the San Francisco Bay Area and beyond.

الحلقات

  1. Where does drug pricing cross the line into gouging?

    ١٥‏/٠١‏/٢٠١٨

    Where does drug pricing cross the line into gouging?

    Big money was evident throughout the 36th J.P. Morgan Healthcare Conference — from the $200 an hour it costs to meet with someone in some hotel lobbies or lounges to the price of drugs. But as life-changing, one-shot-and-you're-done gene therapies emerge as options — with price tags approaching or exceeding $1 million — how much is too much?

    ١٥ من الدقائق
  2. The iPhone, blockchain and other health themes from Stanford Medicine Dean Lloyd Minor

    ١٢‏/٠١‏/٢٠١٨

    The iPhone, blockchain and other health themes from Stanford Medicine Dean Lloyd Minor

    Lloyd Minor, dean of the Stanford University School of Medicine, talks about the trends capturing health care and biotech. Lloyd Minor's list of three challenges that will define health care's future: https://www.linkedin.com/pulse/jpm-2018-three-challenges-define-health-cares-future-lloyd-minor/

    ٢٨ من الدقائق
  3. From full-body scanners to new-age drugs, Mir Imran's passion for 'big, unsolved mysteries'

    ٠٩‏/٠١‏/٢٠١٨

    From full-body scanners to new-age drugs, Mir Imran's passion for 'big, unsolved mysteries'

    Mir Imran developed an early defibrillator and those full-body scanners at airport security. After a career that's also included patents for medical devices, his Rani Therapeutics now is taking on new-age drugs designed to reduce side effects and increase efficacy.

    ٣٩ من الدقائق
  4. How a venture fund weighs risk and spots scientific passion

    ٠٨‏/٠١‏/٢٠١٨

    How a venture fund weighs risk and spots scientific passion

    Nick Naclerio oversaw many deals by life sciences tools maker Illumina Inc. Now he's heading up a $230 million fund, which takes its name from and includes Illumina as an investor.

    ٢٤ من الدقائق
  5. How a startup is using machine learning to speed new Parkinson's, ALS drugs

    ٠٥‏/٠١‏/٢٠١٨

    How a startup is using machine learning to speed new Parkinson's, ALS drugs

    Alice Zhang sees a way of tapping machine learning to accelerate the development of new drugs to treat Parkinson's disease and other brain diseases — and dismiss the ones that won't work.

    ٢٣ من الدقائق
  6. What an emerging drug company is doing to disrupt depression

    ٠٢‏/٠١‏/٢٠١٨

    What an emerging drug company is doing to disrupt depression

    Dr. Atul Mahableshwarkar, hired last summer by BlackThorn Therapeutics as vice president of clinical development, talks about the South San Francisco drug company's attack on depression.

    ٢٩ من الدقائق
  7. How Glenn Close, Billy Crystal and a S.F. nonprofit are conquering the 'last frontier'

    ٢٠‏/١٠‏/٢٠١٧

    How Glenn Close, Billy Crystal and a S.F. nonprofit are conquering the 'last frontier'

    Billy Crystal talks about the award he accepted from Bring Change To Mind, the mental health nonprofit cofounded by Glenn Close, while Close talks about eliminating the stigma of mental disorders and changing how mental health issues are discussed, diagnosed and treated.

    ١٢ من الدقائق
  • ٧ حلقة

التقييمات والمراجعات

٥
من ٥
‫٣ من التقييمات‬

حول

BioFlash is a biweekly podcast, hosted by San Francisco Business Times biotech reporter Ron Leuty. From cancer immunotherapy to drug pricing, we explore the hot topics driving the life sciences ecosystem in the San Francisco Bay Area and beyond.

المعلومات

  • صناع العمل
    San Francisco Business Times
  • سنوات النشاط
    ٢٠١٦ - ٢٠١٨
  • الحلقات
    ٧
  • التقييم
    ملائم
  • حقوق النشر
    © All rights reserved
  • موقع البرنامج على الويب
    BioFlash